| Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages |
51 |
| Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis |
34 |
| Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS |
34 |
| Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations |
33 |
| Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea |
32 |
| Therapeutic effects of human mesenchymal stem cell microvesicles in an ex vivo perfused human lung injured with severe E-coli pneumonia |
29 |
| Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis |
28 |
| Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials |
27 |
| Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester |
26 |
| British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma |
25 |
| Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis |
25 |
| Metabolic phenotype of skeletal muscle in early critical illness |
24 |
| Exacerbation risk and characterisation of the UK's asthma population from infants to old age |
24 |
| Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination |
22 |
| Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor |
21 |
| Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population |
20 |
| Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP study |
19 |
| Help, hinder, hide and harm: what can we learn from the interactions between Pseudomonas aeruginosa and Staphylococcus aureus during respiratory infections? |
19 |
| Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years |
18 |
| A potential role of microvesicle-containing miR-223/142 in lung inflammation |
18 |
| Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease? |
17 |
| Return to work and lost earnings after acute respiratory distress syndrome: a 5-year prospective, longitudinal study of long-term survivors |
16 |
| A population-based prospective cohort study examining the influence of early-life respiratory tract infections on school-age lung function and asthma |
16 |
| Advance care planning for patients with chronic respiratory diseases: a systematic review of preferences and practices |
15 |
| Comparison of a structured home-based rehabilitation programme with conventional supervised pulmonary rehabilitation: a randomised non-inferiority trial |
15 |
| Stability of ARDS subphenotypes over time in two randomised controlled trials |
15 |
| Mechanical stress-induced mast cell degranulation activates TGF-beta 1 signalling pathway in pulmonary fibrosis |
14 |
| Perspectives of survivors, families and researchers on key outcomes for research in acute respiratory failure |
14 |
| Holistic services for people with advanced disease and chronic breathlessness: a systematic review and meta-analysis |
14 |
| Leisure-time vigorous physical activity is associated with better lung function: the prospective ECRHS study |
14 |
| PGC1 alpha repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state |
13 |
| Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomised controlled trials |
13 |
| Randomised controlled trial of adjunctive inspiratory muscle training for patients with COPD |
13 |
| Seasonal temperature variability and emergency hospital admissions for respiratory diseases: a population-based cohort study |
13 |
| Using hyperpolarized Xe-129 MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis |
13 |
| Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway |
13 |
| The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case-control study |
12 |
| Gene correlation network analysis to identify regulatory factors in idiopathic pulmonary fibrosis |
12 |
| Airway obstruction in young adults born extremely preterm or extremely low birth weight in the postsurfactant era |
12 |
| Second round results from the Manchester 'Lung Health Check' community-based targeted lung cancer screening pilot |
12 |
| Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial |
11 |
| British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE) |
11 |
| Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome |
11 |
| At-risk children with asthma (ARC): a systematic review |
11 |
| Brock malignancy risk calculator for pulmonary nodules: validation outside a lung cancer screening population |
11 |
| Lung cancer stage-shift following a symptom awareness campaign |
11 |
| Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients |
11 |
| Intensive versus standard physical rehabilitation therapy in the critically ill (EPICC): a multicentre, parallel-group, randomised controlled trial |
11 |
| Aspergillus and progression of lung disease in children with cystic fibrosis |
11 |
| Risk factors for situs defects and congenital heart disease in primary ciliary dyskinesia |
11 |
